Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery
ConditionEyelid; Wound
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLaboratoires Thea
About this trial
The goal of this non-interventional, open and monocentric study is to evaluate the satisfaction of 30 patients, after 3 months with Blephaderm eyelid cream, as a complementary care in post-eyelid surgery (Blepharopasty or ptosis).
The participant will be asked to use Blephaderm twice a day. The patient satisfaction will be evaluated using a VAS scale.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years old
Patients planning a blepharoplasty or a ptosis surgery in at least one eye.
Patient affiliated to a health social security system
Female of childbearing potential should use a medically accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after the study end.
Disqualifiers
Pregnant or nursing woman or planning a pregnancy during the study.
Patient who had been deprived of their freedom by administrative or legal decision
Minor patient.
Major patient who is under guardianship or who is not able to express his non opposition.
Trial population
A total of 30 patients undergoing blepharoplasty or ptosis surgery
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Cosmetic: Blephaderm
Other interventionPreservative free eyelid cream: Aqua (water), oleyl erucate, trehalose, sodium acrylates copolymer, lecithin, Ophiopogon japonicus root extract, hydrolyzed hyaluronic acid, maltodextrin, tocopherol, sodium hydroxide, phytic acid, Glycine soja (soybean) oil, Helianthus annuus seed oil.
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: Group receiving Blephaderm1 intervention
Trial outcomes
Primary outcomes
1
global satisfaction of the patient on eyelid comfort after 3 months of Bllephaderm® use, assessed at M4, using a VAS from 0 (unsatisfied) to 10 (very satisfied).
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov